Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin and Atorvastatin in Major Depressive Disorders
NCT05792540Phase 2Completed
- Sponsor
- Tanta University
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin, atorvastatin in major depressive disorder (MDD), sponsored by Tanta University. Started Jun 2023; status: completed.
02
Drugs
dapagliflozinatorvastatin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05792540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05792540.